Solution Structure of the Transforming Growth Factor Beta-binding Protein-like Module, a Domain Associated with Matrix Fibrils

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1998 Jan 10

PMID 9362480

Citations 43

Authors

X Yuan

A K Downing

V Knott

P A Handford

Affiliations

Soon will be listed here.

Abstract

Here we describe the high resolution nuclear magnetic resonance (NMR) structure of a transforming growth factor beta (TGF-beta)-binding protein-like (TB) domain, which comes from human fibrillin-1, the protein defective in the Marfan syndrome (MFS). This domain is found in fibrillins and latent TGF-beta-binding proteins (LTBPs) which are localized to fibrillar structures in the extracellular matrix. The TB domain manifests a novel fold which is globular and comprises six antiparallel beta-strands and two alpha-helices. An unusual cysteine triplet conserved in the sequences of TB domains is localized to the hydrophobic core, at the C-terminus of an alpha-helix. The structure is stabilized by four disulfide bonds which pair in a 1-3, 2-6, 4-7, 5-8 pattern, two of which are solvent exposed. Analyses of MFS-causing mutations and the fibrillin-1 cell-binding RGD site provide the first clues to the surface specificity of TB domain interactions. Modelling of a homologous TB domain from LTBP-1 (residues 1018-1080) suggests that hydrophobic contacts may play a role in its interaction with the TGF-beta1 latency-associated peptide.

Citing Articles

A Novel Missense Mutation in the TGF-β-binding Protein-Like Domain 3 of Causes Weill-Marchesani Syndrome with Intellectual Disability.

Hassani M, Taghizadeh S, Farahzad Broujeni A, Habibi M, Banitalebi S, Kasiri M Adv Biomed Res. 2023; 12:114.

PMID: 37288014 PMC: 10241635. DOI: 10.4103/abr.abr_138_22.

Cardiac Complications in Marfan Syndrome: A Review.

Singh J, Wanjari A Cureus. 2022; 14(9):e29800.

PMID: 36340521 PMC: 9622027. DOI: 10.7759/cureus.29800.

The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.

Peeters S, De Kinderen P, Meester J, Verstraeten A, Loeys B Hum Mutat. 2022; 43(7):815-831.

PMID: 35419902 PMC: 9322447. DOI: 10.1002/humu.24383.

Pathophysiology and Pathogenesis of Marfan Syndrome.

Zeigler S, Sloan B, Jones J Adv Exp Med Biol. 2021; 1348:185-206.

PMID: 34807420 PMC: 8915437. DOI: 10.1007/978-3-030-80614-9_8.

Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-β Signaling.

Wheeler J, Ikonomidis J, Jones J Adv Exp Med Biol. 2021; 1348:161-184.

PMID: 34807419 PMC: 8905527. DOI: 10.1007/978-3-030-80614-9_7.

References

Sakai L, Keene D . Fibrillin: monomers and microfibrils. Methods Enzymol. 1994; 245:29-52. DOI: 10.1016/0076-6879(94)45004-8. View

Bairoch A . PROSITE: a dictionary of sites and patterns in proteins. Nucleic Acids Res. 1992; 20 Suppl:2013-8. PMC: 333978. DOI: 10.1093/nar/20.suppl.2013. View

Dietz H, Pyeritz R . Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet. 1995; 4 Spec No:1799-809. DOI: 10.1093/hmg/4.suppl_1.1799. View

Bork P, Downing A, Kieffer B, Campbell I . Structure and distribution of modules in extracellular proteins. Q Rev Biophys. 1996; 29(2):119-67. DOI: 10.1017/s0033583500005783. View

Barton G . Protein multiple sequence alignment and flexible pattern matching. Methods Enzymol. 1990; 183:403-28. DOI: 10.1016/0076-6879(90)83027-7. View

Ambrus Jr J, Pippin J, Joseph A, Xu C, Blumenthal D, Tamayo A . Identification of a cDNA for a human high-molecular-weight B-cell growth factor. Proc Natl Acad Sci U S A. 1993; 90(13):6330-4. PMC: 46922. DOI: 10.1073/pnas.90.13.6330. View

Nilges M . Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J Mol Biol. 1995; 245(5):645-60. DOI: 10.1006/jmbi.1994.0053. View

Taipale J, Saharinen J, Hedman K, Keski-Oja J . Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem. 1996; 44(8):875-89. DOI: 10.1177/44.8.8756760. View

Pereira L, DAlessio M, Ramirez F, Lynch J, Sykes B, Pangilinan T . Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet. 1993; 2(7):961-8. DOI: 10.1093/hmg/2.7.961. View

10.

Downing A, Knott V, Werner J, Cardy C, Campbell I, Handford P . Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell. 1996; 85(4):597-605. DOI: 10.1016/s0092-8674(00)81259-3. View

11.

Garvey K, Oberste M, Elser J, Braun M, Gonda M . Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus. Virology. 1990; 175(2):391-409. DOI: 10.1016/0042-6822(90)90424-p. View

12.

Moren A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L . Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J Biol Chem. 1994; 269(51):32469-78. View

13.

Knott V, Downing A, Cardy C, Handford P . Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1. J Mol Biol. 1996; 255(1):22-7. DOI: 10.1006/jmbi.1996.0003. View

14.

Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K . TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell. 1990; 61(6):1051-61. DOI: 10.1016/0092-8674(90)90069-q. View

15.

Sakamoto H, Broekelmann T, Cheresh D, Ramirez F, Rosenbloom J, Mecham R . Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J Biol Chem. 1996; 271(9):4916-22. View

16.

Koslowsky D, Bhat G, Perrollaz A, Feagin J, Stuart K . The MURF3 gene of T. brucei contains multiple domains of extensive editing and is homologous to a subunit of NADH dehydrogenase. Cell. 1990; 62(5):901-11. DOI: 10.1016/0092-8674(90)90265-g. View

17.

Dallas S, Miyazono K, Skerry T, Mundy G, Bonewald L . Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol. 1995; 131(2):539-49. PMC: 2199978. DOI: 10.1083/jcb.131.2.539. View

18.

Yin W, Smiley E, Germiller J, Mecham R, Florer J, Wenstrup R . Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). J Biol Chem. 1995; 270(17):10147-60. DOI: 10.1074/jbc.270.17.10147. View

19.

Ades L, Haan E, Colley A, Richard R . Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome. J Med Genet. 1996; 33(8):665-71. PMC: 1050701. DOI: 10.1136/jmg.33.8.665. View

20.

Grzesiek S, Bax A . Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins. J Biomol NMR. 1993; 3(2):185-204. DOI: 10.1007/BF00178261. View